FI963251L - Farmaseuttinen valmiste, jossa on plasminogeeniaktivaattoreita - Google Patents

Farmaseuttinen valmiste, jossa on plasminogeeniaktivaattoreita Download PDF

Info

Publication number: FI963251L
Authority: FI; Finland
Prior art keywords: pharmaceutical preparation; preparation containing; plasminogen activators; containing plasminogen; activators
Prior art date: 1994-02-21

Application number

FI963251A

Other languages

English (en)

Swedish (sv)

Other versions

FI963251A0 (fi

FI117925B (fi

Inventor

Ulrich Kohnert

Stephan Fischer

Hans-Joerg Markl

Heinrich Woog

Original Assignee

Boehringer Mannheim Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-02-21

Filing date

1996-08-20

Publication date

1996-08-20

1996-08-20 Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh

1996-08-20 Publication of FI963251A0 publication Critical patent/FI963251A0/fi

1996-08-20 Publication of FI963251L publication Critical patent/FI963251L/fi

2007-04-30 Application granted granted Critical

2007-04-30 Publication of FI117925B publication Critical patent/FI117925B/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Diabetes (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Enzymes And Modification Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FI963251A 1994-02-21 1996-08-20 Farmaseuttinen valmiste, jossa on plasminogeeniaktivaattoreita FI117925B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DE4405426		1994-02-21
DE4405426A DE4405426A1 (de)	1994-02-21	1994-02-21	Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate
EP9500596		1995-02-18
PCT/EP1995/000596 WO1995022347A1 (de)	1994-02-21	1995-02-18	Pharmazeutisches präparat enthaltend plasminogenaktivatoren

Publications (3)

Publication Number	Publication Date
FI963251A0 FI963251A0 (fi)	1996-08-20
FI963251L true FI963251L (fi)	1996-08-20
FI117925B FI117925B (fi)	2007-04-30

Family

ID=6510724

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI963251A FI117925B (fi)	1994-02-21	1996-08-20	Farmaseuttinen valmiste, jossa on plasminogeeniaktivaattoreita

Country Status (26)

Country	Link
US (1)	US5747030A (fi)
EP (1)	EP0746334B1 (fi)
JP (1)	JP3868997B2 (fi)
KR (1)	KR100356934B1 (fi)
CN (1)	CN1170591C (fi)
AT (1)	ATE205091T1 (fi)
AU (1)	AU691881B2 (fi)
BR (1)	BR9506840A (fi)
CA (1)	CA2183755C (fi)
CZ (1)	CZ286682B6 (fi)
DE (2)	DE4405426A1 (fi)
DK (1)	DK0746334T3 (fi)
ES (1)	ES2162913T3 (fi)
FI (1)	FI117925B (fi)
HU (1)	HU219769B (fi)
MX (1)	MX9603515A (fi)
NO (1)	NO317726B1 (fi)
NZ (1)	NZ281607A (fi)
PL (1)	PL181257B1 (fi)
PT (1)	PT746334E (fi)
RU (1)	RU2155067C2 (fi)
SG (1)	SG50567A1 (fi)
SK (1)	SK282827B6 (fi)
TW (1)	TW337997B (fi)
WO (1)	WO1995022347A1 (fi)
ZA (1)	ZA951371B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9702680D0 (sv) *	1997-07-11	1997-07-11	Astra Pharma Prod	New formulation
US6653062B1 (en) *	2000-07-26	2003-11-25	Wisconsin Alumni Research Foundation	Preservation and storage medium for biological materials
US20090214644A1 (en) *	2003-07-31	2009-08-27	Xanodyne Pharmaceuticals, Inc.	Tranexamic acid formulations with reduced adverse effects
US20050025825A1 (en) *	2003-07-31	2005-02-03	Xanodyne Pharmacal, Inc.	Tranexamic acid formulations with reduced adverse effects
US20090215898A1 (en) *	2004-03-04	2009-08-27	Xanodyne Pharmaceuticals, Inc.	Tranexamic acid formulations
US20050244495A1 (en)	2004-03-04	2005-11-03	Xanodyne Pharmaceuticals, Inc.	Tranexamic acid formulations
US7947739B2 (en)	2004-03-04	2011-05-24	Ferring B.V.	Tranexamic acid formulations
US8022106B2 (en) *	2004-03-04	2011-09-20	Ferring B.V.	Tranexamic acid formulations
US20050245614A1 (en) *	2004-03-04	2005-11-03	Xanodyne Pharmaceuticals, Inc.	Tranexamic acid formulations
NZ569108A (en) *	2005-12-20	2011-09-30	Bristol Myers Squibb Co	Formulations of CTLA4Ig stabilised using sugars
US9309316B2 (en)	2005-12-20	2016-04-12	Bristol-Myers Squibb Company	Stable subcutaneous protein formulations and uses thereof
US20100280117A1 (en) *	2009-04-30	2010-11-04	Xanodyne Pharmaceuticals, Inc.	Menorrhagia Instrument and Method for the Treatment of Menstrual Bleeding Disorders
SG10201913874TA (en)	2013-03-15	2020-03-30	Biogen Ma Inc	Factor ix polypeptide formulations
EA038573B1 (ru)	2014-03-24	2021-09-16	Биовератив Терапьютикс Инк.	Лиофилизированный состав, содержащий фактор ix, для предупреждения приступов кровотечения
BE1025996A9 (fr) *	2018-01-19	2020-05-11	Hyloris Dev Sa	Solution orale d’acide tranexamique
US10980757B2 (en) *	2018-09-06	2021-04-20	RTU Pharma SA	Ready-to-use tranexamic acid intravenous solution
BR112023001489A2 (pt) *	2020-08-10	2023-03-14	Chiesi Farm Spa	Formulação de ativador de plasminogênio tecidual

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3718889A1 (de) *	1987-06-05	1988-12-22	Behringwerke Ag	Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
DE3942141A1 (de) *	1989-12-20	1991-06-27	Boehringer Mannheim Gmbh	K2p pro-stabilisierung
DE3942143A1 (de) *	1989-12-20	1991-06-27	Boehringer Mannheim Gmbh	T-pa pro stabilisierung
DE3942144A1 (de) *	1989-12-20	1991-06-27	Boehringer Mannheim Gmbh	Stabilisierung von k1k2p pro

1994
- 1994-02-21 DE DE4405426A patent/DE4405426A1/de not_active Withdrawn
1995
- 1995-02-14 TW TW084101302A patent/TW337997B/zh not_active IP Right Cessation
- 1995-02-18 MX MX9603515A patent/MX9603515A/es not_active IP Right Cessation
- 1995-02-18 US US08/693,226 patent/US5747030A/en not_active Expired - Lifetime
- 1995-02-18 WO PCT/EP1995/000596 patent/WO1995022347A1/de not_active Ceased
- 1995-02-18 NZ NZ281607A patent/NZ281607A/en not_active IP Right Cessation
- 1995-02-18 EP EP95910500A patent/EP0746334B1/de not_active Expired - Lifetime
- 1995-02-18 RU RU96119391/14A patent/RU2155067C2/ru not_active IP Right Cessation
- 1995-02-18 BR BR9506840A patent/BR9506840A/pt not_active IP Right Cessation
- 1995-02-18 DK DK95910500T patent/DK0746334T3/da active
- 1995-02-18 JP JP52159995A patent/JP3868997B2/ja not_active Expired - Fee Related
- 1995-02-18 AT AT95910500T patent/ATE205091T1/de active
- 1995-02-18 HU HU9602284A patent/HU219769B/hu not_active IP Right Cessation
- 1995-02-18 PL PL95315978A patent/PL181257B1/pl not_active IP Right Cessation
- 1995-02-18 DE DE59509580T patent/DE59509580D1/de not_active Expired - Lifetime
- 1995-02-18 CA CA002183755A patent/CA2183755C/en not_active Expired - Lifetime
- 1995-02-18 SG SG1996005074A patent/SG50567A1/en unknown
- 1995-02-18 KR KR1019960704548A patent/KR100356934B1/ko not_active Expired - Fee Related
- 1995-02-18 CN CNB951917323A patent/CN1170591C/zh not_active Expired - Fee Related
- 1995-02-18 AU AU17581/95A patent/AU691881B2/en not_active Ceased
- 1995-02-18 ES ES95910500T patent/ES2162913T3/es not_active Expired - Lifetime
- 1995-02-18 PT PT95910500T patent/PT746334E/pt unknown
- 1995-02-18 SK SK1079-96A patent/SK282827B6/sk not_active IP Right Cessation
- 1995-02-18 CZ CZ19962431A patent/CZ286682B6/cs not_active IP Right Cessation
- 1995-02-20 ZA ZA951371A patent/ZA951371B/xx unknown
1996
- 1996-08-20 NO NO19963460A patent/NO317726B1/no not_active IP Right Cessation
- 1996-08-20 FI FI963251A patent/FI117925B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL181257B1 (pl)	2001-06-29
JP3868997B2 (ja)	2007-01-17
PT746334E (pt)	2002-02-28
FI963251A0 (fi)	1996-08-20
DE59509580D1 (de)	2001-10-11
SG50567A1 (en)	1998-07-20
KR970701059A (ko)	1997-03-17
RU2155067C2 (ru)	2000-08-27
AU691881B2 (en)	1998-05-28
TW337997B (en)	1998-08-11
CA2183755A1 (en)	1995-08-24
NO317726B1 (no)	2004-12-13
HUT74843A (en)	1997-02-28
US5747030A (en)	1998-05-05
HU219769B (hu)	2001-07-30
EP0746334A1 (de)	1996-12-11
DE4405426A1 (de)	1995-08-24
NO963460D0 (no)	1996-08-20
NO963460L (no)	1996-10-18
ATE205091T1 (de)	2001-09-15
WO1995022347A1 (de)	1995-08-24
PL315978A1 (en)	1996-12-23
CZ243196A3 (en)	1997-01-15
EP0746334B1 (de)	2001-09-05
HU9602284D0 (en)	1996-10-28
ZA951371B (en)	1996-08-20
FI117925B (fi)	2007-04-30
KR100356934B1 (ko)	2003-02-26
CN1141592A (zh)	1997-01-29
AU1758195A (en)	1995-09-04
CZ286682B6 (en)	2000-06-14
BR9506840A (pt)	1997-10-14
NZ281607A (en)	1997-04-24
JPH09511495A (ja)	1997-11-18
CA2183755C (en)	2004-02-17
SK107996A3 (en)	1997-04-09
SK282827B6 (sk)	2002-12-03
CN1170591C (zh)	2004-10-13
ES2162913T3 (es)	2002-01-16
MX9603515A (es)	1997-03-29
DK0746334T3 (da)	2001-12-27

Publication	Publication Date	Title
DK0783302T3 (da)	2000-05-29	Lægemidler
HU9603495D0 (en)	1997-02-28	1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
DE69012888D1 (de)	1994-11-03	Plasminogenaktivator.
FI970995L (fi)	1997-04-25	Farmaseuttisia yhdisteitä
FI971018L (fi)	1997-04-18	Farmaseuttisia yhdisteitä
FI963251L (fi)	1996-08-20	Farmaseuttinen valmiste, jossa on plasminogeeniaktivaattoreita
FI893500L (fi)	1990-01-21	Vampyrfladdermussaliv plasminogenaktivatorer.
FI954243A7 (fi)	1996-03-13	Farmaseuttiset yhdisteet
BR9508339A (pt)	1997-09-30	Medicamento
TR199501082A2 (tr)	1996-06-21	Farmasötik formülasyonlar.
NO994619L (no)	1999-11-23	Farmasöytiske blandinger
NO992724D0 (no)	1999-06-04	Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater
EE9800275A (et)	1999-02-15	Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
HUP0004565A3 (en)	2002-12-28	Substituted chroman derivatives, their intermediates and medicines containing the same
NO20003141D0 (no)	2000-06-16	Farmasøytiske blandinger
IT235990Y1 (it)	2000-07-18	Bottiglia
FI1592U1 (fi)	1994-10-26	Spruta, foeretraedesvis injektionsspruta
DK0799238T3 (da)	2000-10-09	14alfa, 17alfa-C2-forbundne 19-nor-progesteronderivater
FI950423A7 (fi)	1995-08-02	Uusia 3-bentsoyyli-3,7-diatsibisyklo(3,3,1)nonaani-yhdisteitä sisältävät lääkeaineet
TR28915A (tr)	1997-08-06	Naftokinon türevleri.
TR199601018A1 (tr)	1997-07-21	Farmasötik bilesikler.
FI950737L (fi)	1995-08-19	Lääkkeitä
FI934317A0 (fi)	1993-10-01	Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
NL193607B (nl)	1999-12-01	Farmaceutisch preparaat dat N-acetylcysteïne bevat.
FI930961A0 (fi)	1993-03-04	Matstation foer koettboskap, saerskilt svin

Legal Events

Date	Code	Title	Description
1999-05-30	HC	Name/ company changed in application	Owner name: ROCHE DIAGNOSTICS GMBH
2007-04-30	FG	Patent granted	Ref document number: 117925 Country of ref document: FI
2010-02-25	PC	Transfer of assignment of patent	Owner name: ACTAVIS GROUP PTC EHF. Free format text: ACTAVIS GROUP PTC EHF.
2014-09-18	MM	Patent lapsed